Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05FOF
|
|||
| Former ID |
DIB003508
|
|||
| Drug Name |
CHS-0214
|
|||
| Indication | Ischemic heart disease [ICD-11: BA40-BA6Z; ICD-10: I20-I25; ICD-9: 410-414] | Phase 3 | [1] | |
| Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0] | Phase 3 | [2], [3] | ||
| Rheumatoid arthritis [ICD-11: FA20] | Phase 3 | [2] | ||
| Company |
Coherus biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02115750) Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.